A/Prof Jonathon Arnold is Deputy Academic Director at the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney, which specialises in the discovery and development of cannabis-based medicines. Jonathon has published over 100 research papers and reports on cannabis and the cannabinoids. He currently leads various projects which examine the efficacy of cannabinoids in preclinical models of disease including epilepsy, cancer and PTSD. In addition, his research explores the role of the endogenous cannabinoid system in various diseases. He has provided expert advice on cannabis and the cannabinoids to the ACT Legislative Assembly, Food Standards Australia New Zealand (FSANZ) and the World Health Organisation (WHO).